XML 113 R95.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes - Accumulated Other Comprehensive Income/(Loss) (Net of Tax) (Parenthetical) (Detail) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Before Income Taxes And Income Tax Expense Benefit [Line Items]    
Obsolete stock written off   $ 4,200
Effective income tax reconciliation amount inventory written off [1] $ 0 $ 909
[1] In 2022, one of Teva’s U.S. subsidiaries was determined to be insolvent for tax purposes (i.e., its liabilities exceeded the fair market value of its assets), mainly in light of its accumulated operational losses. Consequently, Teva recognized on its 2022 tax return, a worthless stock deduction of approximately $4.2 billion, with a related tax benefit of approximately $909 million.